Article

CARDIOVASCULAR DISEASES IN CANCER PATIENTS

Ergashov B.B.Bukhara State Medical Institute, Bukhara, UzbekistanAbdullayev I.A.Bukhara State Medical Institute, Bukhara, Uzbekistan

Zenodo (CERN European Organization for Nuclear Research)repository2022en

ABI

Abstract

Abstract. The development of cardiovascular diseases (CVD) is one of the most common side effects in the treatment of patients with oncopathology as a result of the toxic effect of anticancer treatment on the function and structure of the heart or as a result of the accelerated development of CVD in the presence of already existing cardiovascular risk factors. This article details the various steps involved in cardiovascular monitoring and decision-making before, during, and after cancer treatment, based on the 2016 ESC Guidelines for the Treatment of Cancer and Cardiovascular Toxicity.

Topics

Hermeneutics and Narrative Identity Aging, Elder Care, and Social Issues Health, Medicine and Society

Identifiers

DOI: 10.5281/zenodo.6669937

Citations and references

Cited by 00 references

Metrics — AkademScholar